Brain-on-a-chip

HiPSCs-derived cells-based brain-on-a-chip for drug efficacy and toxicity evaluation.

• Utilizing neuronal cells and astrocytes differentiated from hiPSCs.
• Enables evaluation of drug efficacy and toxicity based on the interaction of neuronal cells and astrocytes.
• Enables modeling of neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Conducting experiments easily and conveniently without the need for complex equipment.